NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘life sciences’

14 June 2016

Providence Equity backs Anju to fund OBA buyout

bank-note-946395_1920 Providence Equity Partners has invested in life sciences software business Anju Software, allowing the latter to buy Online Business Applications.

2 June 2016

Life Sciences Partners closes latest fund at $280m

thermometer-833085_960_720 European specialist investor Life Sciences Partners has closed its latest life sciences fund at its $280m hard cap.

11 May 2016

Longitude launches third life sciences fund with $525m target

health Menlo Park-based venture capital firm Longitude Capital is looking to raise up to $525m for its third life sciences fund, AltAssets can reveal.

9 May 2016

Strategic LP trio help venBio Partners to $315m Fund II close

stem-cell-163711_1280 San Francisco-based life sciences investment firm venBio Partners has raised $315m for its second fund thanks to anchor investments from strategic LPs including Amgen, Merck and Baxalta.

21 January 2016

Abingworth closes life sciences co-development fund above target on $105m

particles-1038688_1920 Life sciences and healthcare investor Abingworth has closed its eleventh life sciences fund on $105m, exceeding the target of $100m.

9 December 2015

Sofinnova beats target for latest flagship life science fund in €300m final close

scientist-with-microscope-996187_1280 Life sciences-focused European venture capital firm Sofinnova Partners has beaten its target for its eighth flagship fund in holding a €300m final close.

19 November 2015

Andreessen Horowitz hires Stanford prof to run new $200m biocomputing fund

robot-707219_1280 US venture capital major Andreessen Horowitz has raised $200m for a new fund targeting bio-computing led by former Stanford University professor Vijay Pande.

10 November 2015

ArchiMed takes control stake in life sciences consultancy Deallus

thermometer-833085_1280 European healthcare specialising private equity firm Archimed has picked up a controlling stake in UK life science industry consultant Deallus.

22 October 2015

SV Life Sciences picked to manage $100m dementia treatment fund

dependent-100345_640 Specialist venture capital firm SV Life Sciences has been hired to manage a new $100m investment fund aimed at supporting and developing novel treatments for dementia.

14 September 2015

Avalon Ventures registers first capital for $300m-targeting Fund XI

dollar-163473_1280 Early-stage IT and life sciences investor Avalon Ventures is eyeing up to 300m for its latest fund.

Page 1 of 2312345...1020...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016